These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 15219376

  • 1. Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis.
    Dayan M, Sthoeger Z, Neiman A, Abarbanel J, Sela M, Mozes E.
    Hum Immunol; 2004 Jun; 65(6):571-7. PubMed ID: 15219376
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice.
    Paas-Rozner M, Dayan M, Paas Y, Changeux JP, Wirguin I, Sela M, Mozes E.
    Proc Natl Acad Sci U S A; 2000 Feb 29; 97(5):2168-73. PubMed ID: 10681457
    [Abstract] [Full Text] [Related]

  • 4. A dual altered peptide ligand inhibits myasthenia gravis associated responses by inducing phosphorylated extracellular-regulated kinase 1,2 that upregulates CD4+CD25+Foxp3+ cells.
    Ben-David H, Venkata Aruna B, Sela M, Mozes E.
    Scand J Immunol; 2007 Jun 29; 65(6):567-76. PubMed ID: 17523950
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An altered peptide ligand inhibits the activities of matrix metalloproteinase-9 and phospholipase C, and inhibits T cell interactions with VCAM-1 induced in vivo by a myasthenogenic T cell epitope.
    Faber-Elmann A, Grabovsky V, Dayan M, Sela M, Alon R, Mozes E.
    FASEB J; 2001 Jan 29; 15(1):187-194. PubMed ID: 11149906
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides.
    Atassi MZ, Oshima M.
    Crit Rev Immunol; 1997 Jan 29; 17(5-6):481-95. PubMed ID: 9419435
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cells.
    Paas-Rozner M, Sela M, Mozes E.
    Proc Natl Acad Sci U S A; 2003 May 27; 100(11):6676-81. PubMed ID: 12743364
    [Abstract] [Full Text] [Related]

  • 11. Autoreactive T cell responses and cytokine patterns reflect resistance to experimental autoimmune myasthenia gravis in Wistar Furth rats.
    Zhang GX, Ma CG, Xiao BG, van de Meide PH, Link H.
    Eur J Immunol; 1996 Nov 27; 26(11):2552-8. PubMed ID: 8921938
    [Abstract] [Full Text] [Related]

  • 12. The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes.
    Paas-Rozner M, Sela M, Mozes E.
    Proc Natl Acad Sci U S A; 2001 Oct 23; 98(22):12642-7. PubMed ID: 11606745
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
    Geluk A, van Meijgaarden KE, Roep BO, Ottenhoff TH.
    J Autoimmun; 1998 Aug 23; 11(4):353-61. PubMed ID: 9776713
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H, Lambert EH, Walser-Kuntz DR, Yasukawa Y, McCormick DJ, Lennon VA.
    J Immunol; 1997 Aug 01; 159(3):1570-7. PubMed ID: 9233656
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells.
    Shi FD, Li H, Wang H, Bai X, van der Meide PH, Link H, Ljunggren HG.
    J Immunol; 1999 May 15; 162(10):5757-63. PubMed ID: 10229808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.